Frazier Healthcare closes Fund VIII on $525m

Fund VIII is the firm's first dedicated growth buyout firm to focus exclusively on healthcare companies in the lower mid-market.

US life sciences and healthcare investment firm Frazier Healthcare Partners has closed its ninth healthcare-focused fund on its $525 million hard-cap.

The fund, Frazier Healthcare Growth Buyout VIII, had initially targeted $500 million. Seattle-based Frazier said it had attracted “strong support from existing and select new limited partners” which included some of the most well-known global endowments, pension funds and financial institutions.

Frazier Health Partners managing general partner Nader Naini told Private Healthcare Investor that around 70 percent of the fund’s investors were re-ups, 60 percent of which came from North America with the remainder from Australia and Europe.

New investors included an Australian LP and “a few” from Europe and the US. The fund is Frazier’s first dedicated growth buyout firm to focus exclusively on healthcare companies in the lower mid-market.

Naini told PHI that the team’s primary focus was likely to be on pharma services, general healthcare services and healthcare distribution.

Read more by visiting http://www.privatehealthcareinvestor.com.